We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current EDEN market cap is 17.2M. The company's latest EPS is GBP -0.0122 and P/E is -2.46.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 1.83M | 1.37M | 1.23M | 1.83M | 3.19M |
| Operating Income | -1.4M | -2.27M | -3.27M | -2.6M | -6.87M |
| Net Income | -1.15M | -2.27M | -2.79M | -2.24M | -6.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 8.87M | 16.92M | 15.03M | 12.91M | 16.59M |
| Total Liabilities | 1.52M | 2M | 2.2M | 2.17M | 3.05M |
| Total Equity | 7.35M | 14.93M | 12.83M | 10.74M | 13.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -1.01M | -1.02M | -1.62M | -683k | -1.7M |
| Investing | -913k | -1.9M | -1.73M | -1.05M | -1.72M |
| Financing | -21k | 9.71M | -90k | -150k | 8.9M |
| Market Cap | 17.2M |
| Price to Earnings Ratio | -2.46 |
| Price to Sales Ratio | 5 |
| Price to Cash Ratio | 2.16 |
| Price to Book Ratio | 1.18 |
| Dividend Yield | - |
| Shares Outstanding | 533.35M |
| Average Volume (1 week) | 791.89k |
| Average Volume (1 Month) | 446.24k |
| 52 Week Change | -35.50% |
| 52 Week High | 5.15 |
| 52 Week Low | 2.975 |
| Spread (Intraday) | 0.15 (4.55%) |
| Company Name | Eden Research Plc |
| Address |
67c innovation drive oxfordshire OX14 4RQ |
| Website | https://www.edenresearch.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
